SCIE期刊CANCER CHEMOTHERAPY AND PHARMACOLOGY 2024/2025影響因子:2.771 (CANCER CHEMOTH PHARM) (0344-5704). (PHARMACOLOGY & PHAR

點燃

Submitted on: 21 May 2012. Revised on: 23 August 2012. Accepted on: 14 October 2012. ___________________CANCER CHEMOTHERAPY AND PHARMACOLOGY

PAD416

Submitted on: 12 August 2020. Revised on: 24 October 2020. Accepted on: 15 November 2020. ___________________CANCER CHEMOTHERAPY AND PHARMACOLOGY

covert

Submitted on: 29 May 2011. Revised on: 09 August 2011. Accepted on: 09 September 2011. ___________________CANCER CHEMOTHERAPY AND PHARMACOLOGY

檢查

Submitted on: 03 April 2018. Revised on: 26 April 2018. Accepted on: 09 June 2018. ___________________CANCER CHEMOTHERAPY AND PHARMACOLOGY

exacerbate

Submitted on: 06 October 2009. Revised on: 11 January 2010. Accepted on: 26 February 2010. ___________________CANCER CHEMOTHERAPY AND PHARMACOLOGY

開始從未

Submitted on: 22 December 2015. Revised on: 26 January 2016. Accepted on: 17 March 2016. ___________________CANCER CHEMOTHERAPY AND PHARMACOLOGY

Subjugate

消毒

細微的差異

Submitted on: 25 January 2008. Revised on: 19 April 2008. Accepted on: 04 June 2008. ___________________CANCER CHEMOTHERAPY AND PHARMACOLOGY

PON

Submitted on: 04 May 2005. Revised on: 20 July 2005. Accepted on: 03 August 2005. ___________________CANCER CHEMOTHERAPY AND PHARMACOLOGY